CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CISTEM focuses on developing advanced microfluidic technologies to create organ-on-a-chip models for studying rare diseases. This project aims to enhance personalized medicine by utilizing patient-derived cells for drug testing and disease understanding.
Many rare diseases cause chronic health problems or are even life-threatening.
The impact on the quality of life of affected patients, of whom many are children, is significant.
To date, a limited but increasing number of so-called orphan drugs (drugs for rare diseases) are reaching patients.
However, the majority of rare diseases are still without any effective treatment.
The development of novel human systems for drug discovery therefore represents a major public health priority.
Microfluidi…
BIOSENSE INSTITUTE - RESEARCH AND DEVELOPMENT INSTITUTE FOR INFORMATION TECHNOLOGIES IN BIOSYSTEMS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, ZARAGOZA
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Spain, Zaragoza
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, MONTREUIL
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Poland, Krakow
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
